コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 participate in DNA damage response via poly(ADP-ribosylation).
2 inhibit Src kinase-dependent phagocytosis by ADP-ribosylation.
3 ner by a nucleotide-type modification called ADP-ribosylation.
4 f poly(ADP-ribosyl) transferases (PARPs) and ADP-ribosylation.
5 of enzymes capable of modifying proteins by ADP-ribosylation.
6 NA repair, but much less is known about mono-ADP-ribosylation.
7 ish a crosstalk between lipoylation and mono-ADP-ribosylation.
8 of the many cellular processes regulated by ADP-ribosylation.
9 d on post-translational modification by mono-ADP-ribosylation.
10 t TCDD-induced TiPARP also targets PEPCK for ADP-ribosylation.
11 reviously unidentified modulatory effects on ADP-ribosylation.
12 he crosstalk between ubiquitination and poly-ADP-ribosylation.
13 ondrial forms of PEPCK were found to undergo ADP-ribosylation.
14 increasing promoter accessibility by histone ADP-ribosylation.
15 k repair but also elevated levels of protein ADP-ribosylation.
16 l for deconvoluting the biochemical roles of ADP-ribosylation.
17 This modification can occur as mono- or poly-ADP-ribosylation.
18 h effects were independent of DNA damage and ADP-ribosylation.
19 ability to hydrolyze PARP-dependent protein ADP-ribosylation.
20 the two major enzymes that control cellular ADP-ribosylation.
21 lts from PARP1-independent excessive protein ADP-ribosylations.
22 nd ARH3) are a family of enzymes to catalyze ADP-ribosylation, a reversible and covalent post-transla
23 improves the overall localization scores for ADP-ribosylation acceptor sites but also boosts ADP-ribo
25 epair, and this effect was dependent on mono-ADP ribosylation activity of poly(ADP-ribose) polymerase
35 itors modestly increased the levels of PARP1 ADP ribosylation and molecular or small-molecule inhibit
36 Unexpectedly, AHR suppression also enhanced ADP-ribosylation and did so by a poly(ADP-ribose) polyme
40 for both amino-acid starvation induced mono-ADP-ribosylation and subsequent Sec body formation and c
41 ies of the different enzymes associated with ADP-ribosylation and the consequences of this PTM on sub
42 domains that interpret either mono- or poly-ADP-ribosylation and the implications for cellular proce
43 r than the IC50 were required to ablate both ADP-ribosylation and XRCC1 chromatin binding following H
46 ease in GAPDH activity, decreased GAPDH poly-ADP-ribosylation, and nuclear translocation of GAPDH.
47 inding to poly (ADP-ribose) at low levels of ADP-ribosylation, and promotes interaction with cellular
48 results provide an example of reversible DNA ADP-ribosylation, and we anticipate potential therapeuti
49 ole in the turnover and recycling of protein ADP-ribosylation, and we have implicated the importance
51 aining microsomes, suggesting a role for the ADP-ribosylation (ARF)-dependent trafficking of cathepsi
52 ith interdomain allosteric coupling, marking ADP ribosylation as a rapid posttranslational mechanism
53 We also failed to identify a role of PI31 ADP-ribosylation as a mechanism for regulation of overal
61 onsistent with this, LPS stimulation-induced ADP-ribosylation at the nucleosome-occupied promoters of
62 0, MacroD1, and MacroD2 proteins can reverse ADP-ribosylation by acting on ADP-ribosylated substrates
65 ase accessibility assays reveal that histone ADP-ribosylation directly destabilizes histone-DNA inter
66 ated kinase (ERK) signaling, Parp1 auto-poly ADP-ribosylation enhances Sox2-Parp1 interactions, and t
67 tyostelium to identify site-specific histone ADP-ribosylation events in vivo and define the ARTs that
74 ily GTPase Arf79F, the Drosophila homolog of ADP ribosylation factor 1 (ARF1), essential for clathrin
75 of two subcomplexes: the membrane-targeting, ADP ribosylation factor 1 (Arf1):GTP-binding betagammade
76 We report a novel role for the small GTPase ADP ribosylation factor 4 (Arf4) in controlling pattern
77 ylinositol 3 kinase (PI3K)-dependent GTPase, ADP ribosylation factor 6 (ARF-6), to stimulate MHC-I in
81 omology protein, and MTV4, which encodes the ADP ribosylation factor GTPase-activating protein nevers
82 cytic and recycling pathways mediated by the ADP ribosylation factor guanine nucleotide exchange fact
83 Pst) DC3000 infection of Arabidopsis, a host ADP ribosylation factor guanine nucleotide exchange fact
86 olgi-localized, gamma adaptin-ear-containing ADP ribosylation factor-binding protein 3 (GGA3) interac
87 ocalized, gamma-adaptin ear domain homology, ADP ribosylation factor-binding protein 3), a multidomai
88 ocalized, gamma-adaptin ear domain homology, ADP ribosylation factor-binding proteins 1 and 2 (GGA1 a
89 ndicating that the responsible BFA-sensitive ADP ribosylation factor-GTP exchange factor (ARF-GEF) is
94 e-activating proteins (GAPs) that act on the ADP-ribosylation factor (ARF) family of small GTPases.
98 results in the sequential recruitment of the ADP-ribosylation factor (Arf)-like protein Arl1; the Arf
100 enetic screen for IpaJ substrates identified ADP-ribosylation factor (ARF)1p and ARF2p, small molecul
102 a specific interaction with the small GTPase ADP-ribosylation factor (ARF5) in its active, GTP-bound
103 calizing, gamma-adaptin ear homology domain, ADP-ribosylation factor (GGA)-binding motif affects the
104 is a 64-kDa protein containing a functional ADP-ribosylation factor (GTP hydrolase, GTPase), GTPase-
105 Although we have showed that the GTPase ADP-ribosylation factor 1 (ARF1) is overexpressed in hig
106 tudies defined the STAU1-binding site within ADP-ribosylation factor 1 (ARF1) mRNA as a 19-base-pair
107 pecifically associated with the small GTPase ADP-ribosylation factor 1 (Arf1) to mediate uniform dist
108 the finiteness of the cyclical activation of ADP-ribosylation factor 1 (Arf1), a fundamental step in
109 ergic receptor (alpha(2B)-AR) interacts with ADP-ribosylation factor 1 (ARF1), a small GTPase involve
110 and cell biological evidence for the role of ADP-ribosylation factor 1 (ARF1)-GTPase and its effector
113 esult of signalling through the small GTPase ADP-ribosylation factor 6 (ARF6) and its activator ARF n
115 ARs control the activity of the small GTPase ADP-ribosylation factor 6 (Arf6) by consecutively recrui
121 as a guanine nucleotide exchange factor for ADP-ribosylation factor 6 (ARF6) that promotes glut4 ves
122 ogic or genetic blockade of the small GTPase ADP-ribosylation factor 6 (arf6) that regulates integrin
127 equires the activation of small GTPase Arf6 (ADP-ribosylation factor 6), which regulates intracellula
128 n active state, which is further enhanced by ADP-ribosylation factor 6, a host cofactor for CTA1.
129 proteinases, RNA, caveolin-1, and the GTPase ADP-ribosylation factor 6, and are biologically active t
130 m toxin substrate 1, p21-activated kinase 1, ADP-ribosylation factor 6, and cell division control pro
131 copy to show that clathrin, dynamin, and the ADP-ribosylation factor 6, three components of the endoc
134 aptor localization: a step that requires the ADP-ribosylation factor ARF, an ATP-dependent step that
135 with Golgi-localized, gamma-ear-containing, ADP-ribosylation factor binding proteins (GGAs), and Arf
139 evelopment associated with gene mutations in ADP-ribosylation factor guanine exchange factor 2 (ARFGE
140 Human mutations in the Filamin A (FLNA) and ADP-ribosylation factor guanine exchange factor 2 [ARFGE
141 nucleotide exchange factors (GEFs), such as ADP-ribosylation factor nucleotide binding site opener (
144 calize to the plasma membrane, caveolae, and ADP-ribosylation factor-6+ (Arf6+) endocytic compartment
145 ) and Golgi-localized, gamma ear-containing, ADP-ribosylation factor-binding proteins (GGAs) are both
146 Human Golgi-localized, gamma-ear-containing, ADP-ribosylation factor-binding proteins (Ggas) bind dir
149 or the function of the brefeldin A-sensitive ADP-ribosylation factor-guanine exchange factors (ARF-GE
150 PP5E is facilitated by another JBTS protein, ADP-ribosylation factor-like 13B (ARL13B), but not by AR
154 report the crucial role of the small GTPase ADP-ribosylation factor-like 8b (Arl8b) in MHC II presen
155 re, we identify a small GTP-binding protein, ADP-ribosylation factor-like 8b (Arl8b), as a critical f
161 d BIG2 activate, through their Sec7 domains, ADP ribosylation factors (Arfs) by accelerating the repl
162 e-exchange protein (BIG) 1 activates class I ADP ribosylation factors (ARFs) by accelerating the repl
165 factors 1 and 2 (BIG1 or BIG2) that activate ADP-ribosylation factors (Arfs) by accelerating the repl
167 nucleotide exchange factors (GEFs) activate ADP-ribosylation factors (ARFs) to facilitate coating of
168 s as a guanine nucleotide exchange factor of ADP-ribosylation factors (Arfs), is critical for Rickett
169 e those regulated by GTP exchange factors on ADP-ribosylation factors GNOM-LIKE1 and HOPM INTERACTOR7
170 nucleotide-exchange protein (BIG)2 activates ADP-ribosylation factors, approximately 20-kDa GTPase pr
171 his approach, we mapped hundreds of sites of ADP-ribosylation for PARPs 1, 2, and 3 across the proteo
173 ignals by the readers and erasers of protein ADP-ribosylation, has been significantly advanced by the
174 unidentified roles for Tiparp, MacroD1, and ADP-ribosylation in AHR-mediated steatohepatitis and let
176 tablish a novel example for the role of mono-ADP-ribosylation in the formation of stress assemblies,
177 aracterized by a specific increase in serine-ADP-ribosylation in vivo under untreated conditions as w
178 In order to visualise both Poly-, and Mono-, ADP-ribosylation in vivo, we engineered specific fluores
180 of the DLK regeneration pathway, that poly-(ADP ribosylation) inhibits axon regeneration across spec
194 lthough redundancy between H2BE18 and H2BE19 ADP-ribosylation is also apparent following DSBs in vivo
201 findings show that proper control of protein ADP-ribosylation levels affected by ARH1 is essential fo
203 well described, the enzymes involved in mono-ADP-ribosylation (MARylation) have been less well invest
205 In this issue, Chambers et al. report that ADP ribosylation of BiP provides a reversible switch tha
206 xin, the disease-causing agent that, through ADP ribosylation of diphthamide, causes irreversible ina
208 d to the known microbial mechanisms, such as ADP ribosylation of G protein alpha-subunits by cholera
211 HES1-induced PARP1 activation leads to self-ADP ribosylation of PARP1, consumption of nicotinamide a
212 its Src kinase by simultaneous amidation and ADP ribosylation of the conserved kinase-domain residue,
213 his manuscript, the transition state for the ADP-ribosylation of acetyllysine is solved for an Archae
215 ATP-like conformation of the W-loop, whereas ADP-ribosylation of Arg-177 forces the W-loop into a con
217 e fungal toxin brefeldin A (BFA) induces the ADP-ribosylation of C-terminal-binding protein-1 short-f
222 ividually but, in combination, catalyzed the ADP-ribosylation of eukaryotic elongation factor 2 and i
223 in III or PE3) inhibits protein synthesis by ADP-ribosylation of eukaryotic elongation factor 2.
225 of both endogenous and exogenous substrates, ADP-ribosylation of exogenous substrates occurred more e
227 lly, HPF1 promotes PARP-1-dependent in trans ADP-ribosylation of histones and limits DNA damage-induc
228 on induces PARP-1 enzymatic activity and the ADP-ribosylation of histones at transcriptionally active
230 tion, stimulating NAD(+)-dependent auto-poly-ADP-ribosylation of poly(ADP-ribose) polymerase 1 (PARP1
234 & Microbe, Vareechon et al. (2017) describe ADP-ribosylation of Ras as a strategy to inhibit assembl
235 chanism for inhibition than observed for the ADP-ribosylation of Ras by ExoS, where ADP-ribosylated R
237 target specific transcripts for regulation; ADP-ribosylation of RNA-regulatory proteins can alter th
238 e (PARP) activity and posttranslational poly-ADP-ribosylation of several regulatory proteins involved
239 hydrolase (PARG), which dynamically regulate ADP-ribosylation of Smad3 and Smad4, two central signali
242 proach for PARPs, which allows PARP-specific ADP-ribosylation of substrates that is suitable for subs
243 bit protein synthesis of mammalian cells via ADP-ribosylation of the eukaryotic elongation factor-2.
246 duced shortly after viral infection via poly-ADP-ribosylation of the RNA-induced silencing complex (R
249 mally used for Ub conjugation to substrates, ADP-ribosylation of the Ub carboxyl terminus precludes u
250 We also found that tankyrase1-mediated poly-ADP-ribosylation of TRF1 is important for both the inter
251 SdeA, from Legionella pneumophila catalyzes ADP-ribosylation of ubiquitin, allowing SdeA to modify s
252 9 heterodimer mediates NAD(+)-dependent mono-ADP-ribosylation of ubiquitin, exclusively in the contex
254 -ADP-ribosylation) or polymeric chains (poly-ADP-ribosylation) of ADP-ribose are conjugated to protei
255 B level, gamma-H2AX foci formation, and poly(ADP-ribosylation) of PARP-1, which were associated with
259 tional modification where single units (mono-ADP-ribosylation) or polymeric chains (poly-ADP-ribosyla
261 PARP1) and erasers (e.g. PARG, ARH3) of poly-ADP-ribosylation (PARylation) are relatively well descri
262 Here, we found unlike PARP1-mediated Poly-ADP-Ribosylation (PARylation) at genomic damage sites, P
264 erases (PARPs) catalyze massive protein poly ADP-ribosylation (PARylation) within seconds after the i
265 -ribose) polymerase 1 (Parp1) catalyzes poly(ADP-ribosylation) (PARylation) and induces replication n
266 chromatin domains surrounding DSBs via poly-ADP-ribosylation, phosphorylation, acetylation, and prot
268 ow that viral macro domains reverse cellular ADP-ribosylation, potentially cutting the signal of a vi
270 n to controlling Axin levels, Tnks-dependent ADP-ribosylation promotes the reprogramming of Axin foll
271 summarizes the current knowledge of nuclear ADP-ribosylation reactions and their role in chromatin p
279 F1; also known as C4orf27) as a regulator of ADP-ribosylation signaling in the DNA damage response.
280 e how a fundamental step in PARP-1-dependent ADP-ribosylation signaling is regulated and suggest that
281 ism and activation, as well as regulation of ADP-ribosylation signals by the readers and erasers of p
283 s identifies DNA damage induced histone mono-ADP-ribosylation sites by specific ARTs in vivo, providi
286 n or inhibition of PARP-1 or mutation of the ADP-ribosylation sites on NELF-E promotes Pol II pausing
287 We demonstrate their utility in identifying ADP-ribosylation sites on Poly(ADP-ribose) Polymerase 1
289 hroughs in proteomics techniques to identify ADP-ribosylation sites, and future developments to provi
290 C-terminal-binding protein-1 short-form/BFA-ADP-ribosylation substrate (CtBP1-S/BARS), a bifunctiona
291 results demonstrate that very low levels of ADP-ribosylation, synthesized by either PARP1 or PARP2,
292 cribe a sirtuin-dependent reversible protein ADP-ribosylation system and establish a crosstalk betwee
293 on triggers an unprecedented display of mono-ADP-ribosylation that governs the formation of Sec body,
294 xins introduce protein modifications such as ADP-ribosylation to manipulate host cell signaling and p
295 Western blotting and cholera toxin-dependent ADP-ribosylation to show the Gs presence in the sperm he
296 en complemented by recent advances that link ADP-ribosylation to stress responses, metabolism, viral
297 Galphai3 are the critical in vivo targets of ADP-ribosylation underlying VAAS elicited by PTX exposur
298 cal processes now known to require PARPs and ADP-ribosylation was practically unimaginable even two d
299 iously unknown PARP downstream targets whose ADP-ribosylation was sensitive to PARP inhibitor treatme
300 catalytic fragment from our studies in auto-ADP-ribosylation, which is mediated through diffusible i
301 in particular, are known to utilize protein ADP-ribosylation, yet very little is known about their e
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。